AMED Amedisys Inc.

Amedisys Welcomes Adam Holton as Chief People Officer

Amedisys Welcomes Adam Holton as Chief People Officer

BATON ROUGE, La., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health, hospice, personal care and high-acuity care company, announced today that Adam Holton will join the Company as Chief People Officer.

With more than 20 years of experience, Holton is an expert in leading people strategies that drive exceptional business outcomes including talent acquisition, total rewards, organizational and leadership development, employee engagement, talent management and metrics and analytics.

Most recently, Holton was the Chief Human Resources Officer at Numotion, an organization dedicated to improving the lives of people with disabilities. He previously served in the same role at CHS, Inc, a F100 diversified global agribusiness cooperative that creates connections to empower agriculture. Holton has also held several HR leadership positions with General Electric, USAA and Bank One.

Holton served for eight years in the United States Marine Corps as an Infantry Officer, stationed at Camp Pendleton, California and Quantico, Virginia. In 2004, he deployed with a Marine Corps reserve Infantry Battalion as a Company Commander to Lutafiyah, Iraq, as a part of Operation Iraqi Freedom.

“At Amedisys, we strive to create an exceptional employee experience because our people are the heart of what we do,” stated President and Chief Executive Officer Chris Gerard. “In an increasingly competitive talent market, the attraction and retention of high performing diverse talent is key, and Adam’s depth of expertise will help us achieve this strategy so we can continue to deliver the highest quality of care to our patients and their families.”

“People are the most valued and essential part of any organization. I am passionate about being a part of a caregiving culture that attracts, supports and develops people to their fullest and helping Amedisys achieve its vision,” stated Chief People Officer Adam Holton. “I’m honored and excited to join this exceptional company and look forward to contributing to its important mission of allowing patients to receive the care they need where they most want to be, in the home.”

About Amedisys:

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice, personal care and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 3,000 hospitals and 90,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 21,000 employees, in 550 care centers in 38 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 445,000 patients in need every year, performing more than 11.5 million visits annually. For more information about the Company, please visit: 

Contact:

Kendra Kimmons

Vice President of Marketing & Communications

225-299-3708



EN
27/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Amedisys Inc.

 PRESS RELEASE

Amedisys Reports First Quarter 2025 Financial Results

Amedisys Reports First Quarter 2025 Financial Results BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025. Three-Month Periods Ended March 31, 2025 and 2024 Net service revenue increased $23.4 million to $594.8 million compared to $571.4 million in 2024.Net income attributable to Amedisys, Inc. of $61.0 million, which is inclusive of merger-related expenses totaling $16.8 million ($16.6 million, net of tax) and a $48.1 million gain on an equity method investment ($35.6 mi...

 PRESS RELEASE

Amedisys Reports Fourth Quarter and Year End 2024 Financial Results

Amedisys Reports Fourth Quarter and Year End 2024 Financial Results BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month Periods Ended December 31, 2024 and 2023 Net service revenue increased $27.3 million to $598.1 million compared to $570.8 million in 2023.Net loss attributable to Amedisys, Inc. of $20.4 million, which is inclusive of merger-related expenses totaling $17.4 million ($15.9 million, net of tax) and a non-cash goodwill and other inta...

 PRESS RELEASE

Amedisys Honors 47 Employees With Annual Spirit of Excellence Award

Amedisys Honors 47 Employees With Annual Spirit of Excellence Award BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the prestigious Spirit of Excellence Awards, one of the company’s highest honors. “Every day, our employees bring warmth, compassion and clinical expertise into the homes of our patients, offering the care they need in the place they most want to be,” said Richard Ashworth, President and Chief Executive Officer. “We are privileged to ...

 PRESS RELEASE

Amedisys Reports Third Quarter 2024 Financial Results

Amedisys Reports Third Quarter 2024 Financial Results BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month Periods Ended September 30, 2024 and 2023 Net service revenue increased $31.5 million to $587.7 million compared to $556.2 million in 2023.Net income attributable to Amedisys, Inc. of $16.9 million, which is inclusive of merger-related expenses totaling $16.7 million ($16.7 million, net of tax) compared to net income attributable...

 PRESS RELEASE

Amedisys has earned the 2023 SHPBest™ Patient Satisfaction Awards

Amedisys has earned the 2023 SHPBest™ Patient Satisfaction Awards BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, has 92 home health and hospice care centers recognized by Strategic Healthcare Programs (SHP) for achieving the highest overall HHCAHPS patient satisfaction or CAHPS Hospice caregiver satisfaction scores of all eligible SHP clients in 2023. This includes 14 care centers awarded Premier Performer, ranking in the top 5%, and 78 care centers awarded Superior Performer,...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch